Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2493332 | 0.81 | MEN1 (0.42) | CYP3A4MAPT | |
| SCHEMBL4742843 | 0.76 | MAOA (0.47) | CYP3A4MAPTUSP2 | |
| SCHEMBL1844264 | 0.75 | ABCB1 (0.34) | — | |
| SCHEMBL1938572 | 0.73 | MAPT (0.50) | CYP3A4MAPTUSP2 | |
| SCHEMBL1937965 | 0.72 | ABCG2 (0.54) | CYP3A4MAPTUSP2 | |
| SCHEMBL28098802 | 0.70 | CYP3A4 (0.48) | CYP3A4MAPT | |
| SCHEMBL23849510 | 0.70 | ABCB1 (0.41) | — | |
| SCHEMBL30132716 | 0.69 | MAPT (0.45) | CYP3A4MAPT | |
| SCHEMBL28417375 | 0.69 | MAPT (0.45) | CYP3A4MAPT | |
| SCHEMBL30132715 | 0.69 | MAPT (0.45) | CYP3A4MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2858641-B1 | IMPROVED METHODS FOR BOTANICAL AND/OR ALGAE EXTRACTION | BASF CORP (US) | 2017-09-06 | — | — | EP | claimed |
| EP-2888012-B1 | ORAL CARE | UNIV PRETORIA (ZA) | 2020-06-17 | — | — | EP | disclosed |
| EP-2888012-A2 | ORAL CARE | University of Pretoria (ZA) | 2015-07-01 | — | — | EP | disclosed |
| US-20150174059-A1 | ORAL CARE | UNIVERSITY OF PRETORIA (ZA) | 2015-06-25 | — | — | US | disclosed |
| WO-2014033625-A2 | ORAL CARE | UNIVERSITY OF PRETORIA (ZA) | 2014-03-06 | — | — | WO | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150174059-A1 | ORAL CARE | NOP2, POLR1C, DPM1 | CYP3A4 1844/4885MAPT 2090/4885USP2 4433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.